Clinical utility of the ESTRO-EORTC classification in oligometastatic disease treated with stereotactic body radiotherapy: a single-institution retrospective study.

Clin Exp Metastasis · 2026 · PMC12923495 · PMID 41718856

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Induced OMD showed a trend toward shorter OS, supporting the utility and reproducibility of the classification in clinical practice.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Our results similarly demonstrated shorter OS in patients with induced OMD compared to those with de novo or repeat OMD, although the difference did not reach statistical significance (Fig. 2 b).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.